1

Artificial intelligence assessment of the potential of tocilizumab along with corticosteroids therapy for the management of COVID-19 evoked acute respiratory distress syndrome

aejobqdn3svlu
Acute respiratory distress syndrome (ARDS). associated with high mortality rate. affects up to 67% of hospitalized COVID-19 patients. Early evidence indicated that the pathogenesis of COVID-19 evoked ARDS is. https://www.fitnessgravesyardes.shop/product-category/hr-cable/
Report this page

Comments

    HTML is allowed

Who Upvoted this Story